James Buchanan
Impact in
-
- Antibiotic Use and Resistance
- Genetics top 5%
- Genomics and Rare Diseases
- Genomic variations and chromosomal abnormalities
- BRCA gene mutations in cancer
Papers in
- Genetics 21
- Genomics and Rare Diseases 16
- Inflammatory Bowel Disease 3
- BRCA gene mutations in cancer 3
-
- Health Systems, Economic Evaluations, Quality of Life 15
- Co-authors
- Sarah Wordsworth (40 shared papers)Jenny C. Taylor (8 shared papers)Katharina Schwarze (3 shared papers)Anna Schuh (4 shared papers)Lucy Abel (4 shared papers)Laurence Roope (7 shared papers)A. Sarah Walker (7 shared papers)Koen B. Pouwels (6 shared papers)
- Journals
- Value in Health (8 papers)PharmacoEconomics (5 papers)Applied Health Economics and Health Policy (4 papers)PLoS ONE (2 papers)Antibiotics (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
James Buchanan
75 papers receiving 2.0k citations
James Buchanan's Hit Papers
Peers
Comparison fields: 5 of 182
- Applied Microbiology and Biotechnology 96
- Genetics 477
- Molecular Medicine 85
- Cancer Research 149
- Economics and Econometrics 246
Countries citing papers authored by James Buchanan
This map shows the geographic impact of James Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Buchanan more than expected).
Fields of papers citing papers by James Buchanan
This network shows the impact of papers produced by James Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Buchanan. The network helps show where James Buchanan may publish in the future.
Co-authors
The 25 scholars most cited alongside James Buchanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The challenge of antimicrobial resistance: What economics can contribute Hit paper breakdown → | 2019 | 414 |
| 2 | Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature Hit paper breakdown → | 2018 | 358 |
| 3 | 2019 | 146 | |
| 4 | 2013 | 82 | |
| 5 | 1995 | 64 | |
| 6 | 2018 | 60 | |
| 7 | 2018 | 59 | |
| 8 | 2021 | 50 | |
| 9 | Revenue Implications of Money Creation under Leviathan | 1981 | 35 |
| 10 | 2020 | 35 | |
| 11 | 2022 | 32 | |
| 12 | 2016 | 32 | |
| 13 | 2011 | 31 | |
| 14 | 2021 | 31 | |
| 15 | 2010 | 29 | |
| 16 | 2007 | 27 | |
| 17 | 1986 | 27 | |
| 18 | 2016 | 26 | |
| 19 | 1973 | 26 | |
| 20 | 2007 | 25 |
About James Buchanan
James Buchanan is a scholar working on Genetics, Economics and Econometrics, Pediatrics, Perinatology and Child Health, Applied Microbiology and Biotechnology and Pathology and Forensic Medicine, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (16 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Antibiotic Use and Resistance (6 papers), Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers), Child and Animal Learning Development (4 papers), Inflammatory Bowel Disease (3 papers) and BRCA gene mutations in cancer (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (96 citations), Genetics (477 citations), Molecular Medicine (85 citations), Cancer Research (149 citations) and Economics and Econometrics (246 citations). James Buchanan has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Sarah Wordsworth, Jenny C. Taylor, Katharina Schwarze, Anna Schuh, Lucy Abel, Laurence Roope, A. Sarah Walker, Koen B. Pouwels, Julie V. Robotham and Christopher Butler. Their work appears in journals such as Value in Health, PharmacoEconomics, Applied Health Economics and Health Policy, PLoS ONE and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.